Therapeutic use of atrial natriuretic factor (Q35457088)

8 August 2017

1 reference

title

Therapeutic use of atrial natriuretic factor (English)

1 reference

8 August 2017

Connell JM

1

1 reference

8 August 2017

Jardine AG

series ordinal

2

1 reference

8 August 2017

Northridge DB

series ordinal

3

1 reference

8 August 2017

language of work or name

English

0 references

publication date

1 August 1992

1 reference

British Journal of Clinical Pharmacology

8 August 2017

published in

1 reference

8 August 2017

volume

34

1 reference

8 August 2017

issue

2

1 reference

8 August 2017

page(s)

102-105

1 reference

A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats

8 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1381525

Role of endopeptidase-24.11 in the inactivation of atrial natriuretic peptide

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1381525

A membrane form of guanylate cyclase is an atrial natriuretic peptide receptor

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1381525

Atrial natriuretic peptide: water and electrolyte homeostasis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1381525

Low-dose infusion of atrial natriuretic factor in mild essential hypertension.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1381525

Antihypertensive effect of a 5-day infusion of atrial natriuretic factor in humans

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1381525

Neutral endopeptidase 24.11 (enkephalinase) and related regulators of peptide hormones

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1381525

Endothelins come home to roost

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1381525

Inhibition of the metabolism of atrial natriuretic factor causes diuresis and natriuresis in chronic heart failure

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1381525

Inhibition of endopeptidase EC 24.11 in humans. Renal and endocrine effects

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1381525

Atrial natriuretic factor in chronic heart failure

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1381525

Antihypertensive activity during inhibition of neutral endopeptidase and angiotensin converting enzyme

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1381525

Candoxatril, an orally active neutral endopeptidase inhibitor, raises plasma atrial natriuretic factor and is natriuretic in essential hypertension

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1381525

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

12 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1365-2125.1992.TB04117.X

Antihypertensive activity of sinorphan

21 January 2018

1 reference

12 December 2020

Cardiorenal actions of neutral endopeptidase inhibition in experimental congestive heart failure

1 reference

12 December 2020

The atriopeptidase inhibitor UK 69,578 increases atrial natriuretic factor and causes a natriuresis in normal humans

1 reference

12 December 2020

Atrial natriuretic factor-potentiating and antihypertensive activity of SCH 34826. An orally active neutral metalloendopeptidase inhibitor

1 reference

12 December 2020

Clearance function of type C receptors of atrial natriuretic factor in rats

1 reference

12 December 2020

Enkephalinase inhibition increases plasma atrial natriuretic peptide levels, glomerular filtration rate, and urinary sodium excretion in rats with reduced renal mass

1 reference

12 December 2020

Decreased density of binding sites for atrial natriuretic peptide on platelets of patients with severe congestive heart failure

1 reference

12 December 2020

Low dose infusions of 26- and 28-amino acid human atrial natriuretic peptides in normal man

1 reference

12 December 2020

EC 24.11 Inhibition in Man Alters Clearance of Atrial Natriuretic Peptide*

1 reference

12 December 2020

Inhibition of Neutral Endopeptidase (EC 3.4.24.11) Leads to An Atrial Natriuretic Factor-Mediated Natriuretic, Diuretic and Antihypertensive Response in Rodents

1 reference

12 December 2020

Effect of sinorphan on plasma atrial natriuretic factor in congestive heart failure

1 reference

12 December 2020

Endogenous atrial natriuretic factor after endopeptidase 24.11 inhibition by Thiorphan

1 reference

12 December 2020

Neutral endopeptidase inhibition potentiates the renal actions of atrial natriuretic factor

1 reference

12 December 2020

Specific inhibitors of endopeptidase 24.11 inhibit the metabolism of atrial natriuretic peptides in vitro and in vivo

1 reference

12 December 2020

UK-69,578, a novel inhibitor of EC 3.4.24.11 which increases endogenous ANF levels and is natriuretic and diuretic

1 reference

12 December 2020

Potentiation of renal effects of atrial natriuretic factor-(99-126) by SQ 29,072

1 reference

12 December 2020

SCH 39370, a neutral metalloendopeptidase inhibitor, potentiates biological responses to atrial natriuretic factor and lowers blood pressure in desoxycorticosterone acetate-sodium hypertensive rats

1 reference

12 December 2020

Physiological role of silent receptors of atrial natriuretic factor

1 reference

12 December 2020

Renal, haemodynamic, and hormonal effects of human alpha atrial natriuretic peptide in healthy volunteers

1 reference

12 December 2020

Plasma levels and cardiovascular, endocrine, and excretory effects of atrial natriuretic peptide during different sodium intakes in man

1 reference

12 December 2020

10.1111/J.1365-2125.1992.TB04117.X

Identifiers

DOI

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/uf7joj6mzfbqtelnwnwips6kte

30 July 2022

release_uf7joj6mzfbqtelnwnwips6kte

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/uf7joj6mzfbqtelnwnwips6kte

30 July 2022

https://api.fatcat.wiki/v0/release/uf7joj6mzfbqtelnwnwips6kte

1 reference

30 July 2022

https://api.fatcat.wiki/v0/release/uf7joj6mzfbqtelnwnwips6kte

1 reference

30 July 2022